"The VISION Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension"

PHASE3TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2006

Primary Completion Date

December 1, 2007

Study Completion Date

July 1, 2008

Conditions

Pulmonary Hypertension

Interventions

DRUG

Inhaled Iloprost (5 μg)

iloprost inhalation solution (Ventavis) (5 μg)

DRUG

Inhaled Placebo

inhaled placebo

DRUG

Sildenafil

oral sildenafil (dosage between 60 and 300 mg/day)

DRUG

Bosentan

oral bosentan (dosage between 62.5 and 125 mg BID)